SBRT on Oligoprogressive Lesions: Benefit in Lung Cancer

Stereotactic body radiation therapy (SBRT) significantly improved progression-free survival in oligoprogressive, metastatic lung cancer, but not breast cancer.

Related Keywords

Washington University ,Missouri ,United States ,New York ,Memorial Sloan Kettering Cancer Center ,Chicago ,Illinois ,Clifford Robinson ,C Jillian Tsai ,American Society For Radiation Oncology ,American Society ,Radiation Oncology ,Response Evaluation ,Positron Emission Tomography Response Criteria ,Solid Tumors ,For Results ,Medscape Medical ,Breast Cancer ,Alignant Breast Neoplasm ,Radiation Dose ,Targeted Therapy ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,